431 related articles for article (PubMed ID: 10657675)
41. CD40 activation does not protect chronic lymphocytic leukemia B cells from apoptosis induced by cytotoxic T lymphocytes.
Chu P; Wierda WG; Kipps TJ
Blood; 2000 Jun; 95(12):3853-8. PubMed ID: 10845920
[TBL] [Abstract][Full Text] [Related]
42. Aberrant splicing of the tumor suppressor CYLD promotes the development of chronic lymphocytic leukemia via sustained NF-κB signaling.
Hahn M; Bürckert JP; Luttenberger CA; Klebow S; Hess M; Al-Maarri M; Vogt M; Reißig S; Hallek M; Wienecke-Baldacchino A; Buch T; Muller CP; Pallasch CP; Wunderlich FT; Waisman A; Hövelmeyer N
Leukemia; 2018 Jan; 32(1):72-82. PubMed ID: 28566736
[TBL] [Abstract][Full Text] [Related]
43. Expression, regulation, and function of B cell-expressed CD154 in germinal centers.
Grammer AC; McFarland RD; Heaney J; Darnell BF; Lipsky PE
J Immunol; 1999 Oct; 163(8):4150-9. PubMed ID: 10510350
[TBL] [Abstract][Full Text] [Related]
44. miR-29 modulates CD40 signaling in chronic lymphocytic leukemia by targeting TRAF4: an axis affected by BCR inhibitors.
Sharma S; Pavlasova GM; Seda V; Cerna KA; Vojackova E; Filip D; Ondrisova L; Sandova V; Kostalova L; Zeni PF; Borsky M; Oppelt J; Liskova K; Kren L; Janikova A; Pospisilova S; Fernandes SM; Shehata M; Rassenti LZ; Jaeger U; Doubek M; Davids MS; Brown JR; Mayer J; Kipps TJ; Mraz M
Blood; 2021 May; 137(18):2481-2494. PubMed ID: 33171493
[TBL] [Abstract][Full Text] [Related]
45. Unique CD40-mediated biological program in B cell activation requires both type 1 and type 2 NF-kappaB activation pathways.
Zarnegar B; He JQ; Oganesyan G; Hoffmann A; Baltimore D; Cheng G
Proc Natl Acad Sci U S A; 2004 May; 101(21):8108-13. PubMed ID: 15148378
[TBL] [Abstract][Full Text] [Related]
46. CD40 triggering enhances fludarabine-induced apoptosis of chronic lymphocytic leukemia B-cells through autocrine release of tumor necrosis factor-alpha and interferon-gama and tumor necrosis factor receptor-I-II upregulation.
de Totero D; Tazzari PL; Capaia M; Montera MP; Clavio M; Balleari E; Foa R; Gobbi M
Haematologica; 2003 Feb; 88(2):148-58. PubMed ID: 12604404
[TBL] [Abstract][Full Text] [Related]
47. Pharmacological inhibitors of NF-kappaB accelerate apoptosis in chronic lymphocytic leukaemia cells.
Pickering BM; de Mel S; Lee M; Howell M; Habens F; Dallman CL; Neville LA; Potter KN; Mann J; Mann DA; Johnson PW; Stevenson FK; Packham G
Oncogene; 2007 Feb; 26(8):1166-77. PubMed ID: 16924235
[TBL] [Abstract][Full Text] [Related]
48. CD40 engagement prevents peroxisome proliferator-activated receptor gamma agonist-induced apoptosis of B lymphocytes and B lymphoma cells by an NF-kappaB-dependent mechanism.
Ray DM; Akbiyik F; Bernstein SH; Phipps RP
J Immunol; 2005 Apr; 174(7):4060-9. PubMed ID: 15778364
[TBL] [Abstract][Full Text] [Related]
49. Tumor necrosis factor receptor-associated factor 1 gene overexpression in B-cell chronic lymphocytic leukemia: analysis of NF-kappa B/Rel-regulated inhibitors of apoptosis.
Munzert G; Kirchner D; Stobbe H; Bergmann L; Schmid RM; Döhner H; Heimpel H
Blood; 2002 Nov; 100(10):3749-56. PubMed ID: 12411322
[TBL] [Abstract][Full Text] [Related]
50. Constitutive activation of NF-κB signaling by NOTCH1 mutations in chronic lymphocytic leukemia.
Xu ZS; Zhang JS; Zhang JY; Wu SQ; Xiong DL; Chen HJ; Chen ZZ; Zhan R
Oncol Rep; 2015 Apr; 33(4):1609-14. PubMed ID: 25633905
[TBL] [Abstract][Full Text] [Related]
51. [BAY11-7082 and Lactacystein in CD154-induced NF-kappaB activation].
Zhang X; Zhang W; Zeng XF; Zhang FC; Tang FL; Yu MX
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Oct; 26(5):488-91. PubMed ID: 15562757
[TBL] [Abstract][Full Text] [Related]
52. The proteasome inhibitor carfilzomib functions independently of p53 to induce cytotoxicity and an atypical NF-κB response in chronic lymphocytic leukemia cells.
Gupta SV; Hertlein E; Lu Y; Sass EJ; Lapalombella R; Chen TL; Davis ME; Woyach JA; Lehman A; Jarjoura D; Byrd JC; Lucas DM
Clin Cancer Res; 2013 May; 19(9):2406-19. PubMed ID: 23515408
[TBL] [Abstract][Full Text] [Related]
53. Microenvironmental stromal cells abrogate NF-κB inhibitor-induced apoptosis in chronic lymphocytic leukemia.
Simon-Gabriel CP; Foerster K; Saleem S; Bleckmann D; Benkisser-Petersen M; Thornton N; Umezawa K; Decker S; Burger M; Veelken H; Claus R; Dierks C; Duyster J; Zirlik K
Haematologica; 2018 Jan; 103(1):136-147. PubMed ID: 29122993
[TBL] [Abstract][Full Text] [Related]
54. Constitutively activated Notch signaling is involved in survival and apoptosis resistance of B-CLL cells.
Rosati E; Sabatini R; Rampino G; Tabilio A; Di Ianni M; Fettucciari K; Bartoli A; Coaccioli S; Screpanti I; Marconi P
Blood; 2009 Jan; 113(4):856-65. PubMed ID: 18796623
[TBL] [Abstract][Full Text] [Related]
55. Effects of preactivated autologous T lymphocytes on CD80, CD86 and CD95 expression by chronic lymphocytic leukemia B cells.
Romano C; De Fanis U; Sellitto A; Dalla Mora L; Chiurazzi F; Giunta R; Rotoli B; Lucivero G
Leuk Lymphoma; 2003 Nov; 44(11):1963-71. PubMed ID: 14738151
[TBL] [Abstract][Full Text] [Related]
56. Elevated levels of biologically active soluble CD40 ligand in the serum of patients with chronic lymphocytic leukaemia.
Younes A; Snell V; Consoli U; Clodi K; Zhao S; Palmer JL; Thomas EK; Armitage RJ; Andreeff M
Br J Haematol; 1998 Jan; 100(1):135-41. PubMed ID: 9450802
[TBL] [Abstract][Full Text] [Related]
57. Fas resistance of leukemic eosinophils is due to activation of NF-kappa B by Fas ligation.
Qin Y; Camoretti-Mercado B; Blokh L; Long CG; Ko FD; Hamann KJ
J Immunol; 2002 Oct; 169(7):3536-44. PubMed ID: 12244143
[TBL] [Abstract][Full Text] [Related]
58. NF-kappaB is involved in the regulation of CD154 (CD40 ligand) expression in primary human T cells.
Srahna M; Remacle JE; Annamalai K; Pype S; Huylebroeck D; Boogaerts MA; Vandenberghe P
Clin Exp Immunol; 2001 Aug; 125(2):229-36. PubMed ID: 11529914
[TBL] [Abstract][Full Text] [Related]
59. Direct cellular interaction with activated CD4(+) T cells overcomes hyporesponsiveness of B-cell chronic lymphocytic leukemia in vitro.
Tretter T; Schuler M; Schneller F; Brass U; Esswein M; Aman MJ; Huber C; Peschel C
Cell Immunol; 1998 Oct; 189(1):41-50. PubMed ID: 9758693
[TBL] [Abstract][Full Text] [Related]
60. CD40 stimulation of B-cell chronic lymphocytic leukaemia cells enhances the anti-apoptotic profile, but also Bid expression and cells remain susceptible to autologous cytotoxic T-lymphocyte attack.
Kater AP; Evers LM; Remmerswaal EB; Jaspers A; Oosterwijk MF; van Lier RA; van Oers MH; Eldering E
Br J Haematol; 2004 Nov; 127(4):404-15. PubMed ID: 15521917
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]